Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group)
- PMID: 19684147
- DOI: 10.3899/jrheum.090369
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group)
Abstract
Objective: Traditional outcome measures in randomized controlled trials (RCT) include well-established response criteria as well as ACR EULAR responses using Disease Activity Score 44 (DAS44)/DAS28 to assess improvement; however, a measure to assess worsening of disease has yet to be developed. This special interest group (SIG) was established to develop an evidence-based, consensus-driven standard definition of "flare" in rheumatoid arthritis (RA).
Methods: At OMERACT 8, the need for a standardized definition of RA flare was recognized; interested individuals developed a proposal to form a SIG. A literature review was performed to identify publications and abstracts with flare definitions applied in RA, JIA, and lupus RCT as well as concerning patient perspectives on disease worsening. A SIG was held at OMERACT 9 with breakout sessions for patients and investigators.
Results: The RA flare SIG was attended by about 120 participants, including 11 patients. Patients and investigators held separate breakout sessions to discuss various aspects of disease worsening. The following consensus was obtained at OMERACT 9: a working definition of flare should indicate worsening of disease activity (88%), persistence, and duration as critical elements (77%), and consideration of change or increase in therapy (74%).
Conclusion: A working definition of RA flare was developed based on these votes: flare is any worsening of disease activity that would, if persistent, in most cases lead to initiation or change of therapy; and a flare represents a cluster of symptoms of sufficient duration and intensity to require initiation, change, or increase in therapy. Using this working definition, evaluation of candidate domains will be conducted via Delphi exercise and further informed by patient focus groups. Validation of candidate definitions in appropriate RCT will be required.
Similar articles
-
Minimal disease activity for rheumatoid arthritis: a preliminary definition.J Rheumatol. 2005 Oct;32(10):2016-24. J Rheumatol. 2005. PMID: 16206362
-
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.J Rheumatol. 2014 Apr;41(4):799-809. doi: 10.3899/jrheum.131252. Epub 2014 Mar 1. J Rheumatol. 2014. PMID: 24584927 Free PMC article. Review.
-
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.J Rheumatol. 2011 Aug;38(8):1745-50. doi: 10.3899/jrheum.110400. J Rheumatol. 2011. PMID: 21807796
-
A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the 'FLARE' instrument.Ann Rheum Dis. 2012 Jul;71(7):1110-6. doi: 10.1136/ard.2011.150656. Epub 2011 Nov 9. Ann Rheum Dis. 2012. PMID: 22072015
-
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.J Rheumatol. 1993 Mar;20(3):561-5. J Rheumatol. 1993. PMID: 8478874
Cited by
-
Artificial intelligence in rheumatoid arthritis: potential applications and future implications.Front Med (Lausanne). 2023 Nov 16;10:1280312. doi: 10.3389/fmed.2023.1280312. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034534 Free PMC article. Review.
-
The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).Clin Rheumatol. 2020 Jan;39(1):189-199. doi: 10.1007/s10067-019-04755-3. Epub 2019 Sep 6. Clin Rheumatol. 2020. PMID: 31493148
-
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.J Rheumatol. 2017 Oct;44(10):1536-1543. doi: 10.3899/jrheum.161145. Epub 2017 Aug 15. J Rheumatol. 2017. PMID: 28811351 Free PMC article.
-
Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience.Ther Adv Musculoskelet Dis. 2021 May 10;13:1759720X211014019. doi: 10.1177/1759720X211014019. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 34025783 Free PMC article.
-
Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis.Rheumatol Int. 2015 Aug;35(8):1325-33. doi: 10.1007/s00296-015-3235-z. Epub 2015 Feb 28. Rheumatol Int. 2015. PMID: 25724472 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical